Skip to main content

Edesa Biotech, Inc.

EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001540159

No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $31.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Edesa Biotech, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Edesa Biotech, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Edesa Biotech, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Nijhawan PardeepChief Executive Officer899,100Sep 1, 202620
Olson Charles VDirector30,000May 29, 20261
Sistilli CarloDirector49,417May 29, 20261
MacDonald Sean ArthurDirector41,054May 29, 20261
Brooks Michael JPresident291,479May 29, 20262
Marshall PatrickDirector71,666May 29, 20261
Chypyha JoanDirector30,029May 29, 20261
Liu Da DavidDirector24,501May 29, 20261
Weiler Peter J.Chief Financial Officer129,609May 29, 20261
Pardeep Nijhawan Medicine Professional Corp10% Owner341,702IndirectMar 25, 20240
Lemieux StephenChief Financial Officer17,400Aug 4, 20230
Oakes Frank R.Director–Jul 24, 20230
Lumira Capital Investment Management Inc.10% Owner150,275IndirectJan 11, 20230
van der Velden Peter10% Owner150,275IndirectJan 11, 20230
Niffenegger KathiChief Financial Officer10,715IndirectNov 4, 20220
Chao Jennifer MDirector–Mar 30, 20220
Johnson Lorin KDirector–Mar 7, 20220
Pay Paul WilliamDirector–Mar 7, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 11, 2026 (view filing)Feb 2613 daysLateBrooks Michael JPresidentPPurchase+2.00K$1.57+$3.14K+0.9%226.9K after
Mar 10, 2026 (view filing)Mar 10Same dayNijhawan PardeepChief Executive OfficerPPurchase+1.00K$6.60+$6.60K+0.2%628.8K after
Mar 6, 2026 (view filing)Mar 51 dayNijhawan PardeepChief Executive OfficerPPurchase+10.0K$3.90+$39.0K+2.5%402.7K after
Mar 5, 2026 (view filing)Mar 41 dayNijhawan PardeepChief Executive OfficerPPurchase+10.0K$4.26+$42.6K+2.6%392.7K after
Mar 4, 2026 (view filing)Mar 31 dayNijhawan PardeepChief Executive OfficerPPurchase+10.0K$3.63+$36.3K+2.7%382.7K after
Mar 3, 2026 (view filing)Mar 21 dayNijhawan PardeepChief Executive OfficerPPurchase+2.00K$2.00+$4.00K+0.3%627.8K after
Mar 3, 2026 (view filing)Mar 21 dayNijhawan PardeepChief Executive OfficerPPurchase+1.00K$2.28+$2.28K+0.3%372.7K after
Mar 2, 2026 (view filing)Feb 264 daysNijhawan PardeepChief Executive OfficerPPurchase+20.6K$1.58+$32.5K+3.5%615.8K after
Mar 2, 2026 (view filing)Feb 273 daysNijhawan PardeepChief Executive OfficerPPurchase+30.0K$2.22+$66.6K+8.8%371.7K after
Mar 25, 2024 (view filing)7:00 PM ETMar 25Same dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+5.00K$4.00+$20.0K+1.5%341.7K after
Jan 11, 2023 (view filing)3:42 PM ETJan 9-102 daysLumira Capital Investment Management Inc. and 1 other10% OwnerSSaleCommon share−297.5K$2.65−$787.7K−66.4%150.3K after4 lots
Jul 5, 2022 (view filing)1:38 PM ETJun 305 daysNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+20.0K$1.60+$32.1K+3.5%594.8K after
Jun 30, 2022 (view filing)Jun 291 dayBrooks Michael JPresidentPPurchase+3.00K$1.49+$4.47K+12.9%26.2K after
Jun 21, 2022 (view filing)Jun 165 daysBrooks Michael JPresidentPPurchase+3.00K$1.61+$4.83K+14.8%23.2K after
May 31, 2022 (view filing)9:00 AM ETMay 274 daysNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+5.00K$1.92+$9.60K+0.9%574.8K after
May 26, 2022 (view filing)May 251 dayBrooks Michael JPresidentPPurchase+3.50K$1.74+$6.09K+20.9%20.2K after
May 25, 2022 (view filing)12:13 PM ETMay 241 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$1.80+$3.60K+0.4%569.8K after
Apr 1, 2022 (view filing)10:56 AM ETMar 311 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$2.99+$5.97K+0.4%567.8K after
Mar 31, 2022 (view filing)10:52 AM ETMar 301 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$3.05+$6.10K+0.4%565.8K after
Mar 30, 2022 (view filing)12:47 PM ETMar 291 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$3.02+$6.03K+0.4%563.8K after
Mar 21, 2022 (view filing)10:27 AM ETMar 183 daysNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$3.85+$7.70K+0.4%561.8K after
Mar 18, 2022 (view filing)11:26 AM ETMar 171 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$3.26+$6.52K+0.4%559.8K after2 lots
Mar 16, 2022 (view filing)11:17 AM ETMar 151 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+2.00K$2.80+$5.60K+0.4%557.8K after
Mar 15, 2022 (view filing)Mar 141 dayBrooks Michael JPresidentPPurchase+1.25K$2.79+$3.49K+8.1%16.7K after
Mar 14, 2022 (view filing)1:59 PM ETMar 113 daysNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+7.00K$3.09+$21.7K+1.3%555.8K after2 lots
Mar 11, 2022 (view filing)Mar 101 dayBrooks Michael JPresidentPPurchase+1.00K$3.22+$3.22K+6.9%15.5K after
Mar 10, 2022 (view filing)11:10 AM ETMar 91 dayNijhawan Pardeep and 1 otherChief Executive OfficerPPurchase+1.50K$3.05+$4.57K+0.3%548.8K after
Mar 9, 2022 (view filing)Mar 81 dayBrooks Michael JPresidentPPurchase+1.25K$2.90+$3.63K+9.4%14.5K after